APA (7th ed.) Citation

H, X., TJ, K., C, L., NV, R., Z, B., C, L., . . . LA, P. (2025). Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment. Human vaccines & immunotherapeutics, 21(1), 2589647. https://doi.org/10.1080/21645515.2025.2589647

Chicago Style (17th ed.) Citation

H, Xue, et al. "Neutralizing Antibody Responses to the Primary Series of a COVID-19 MRNA Vaccine in the Cancer Cohort Under Active Treatment." Human Vaccines & Immunotherapeutics 21, no. 1 (2025): 2589647. https://doi.org/10.1080/21645515.2025.2589647.

MLA (9th ed.) Citation

H, Xue, et al. "Neutralizing Antibody Responses to the Primary Series of a COVID-19 MRNA Vaccine in the Cancer Cohort Under Active Treatment." Human Vaccines & Immunotherapeutics, vol. 21, no. 1, 2025, p. 2589647, https://doi.org/10.1080/21645515.2025.2589647.